DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
Neuroblastoma (NB) is one of the most frequently occurring extracranial solid tumors of childhood (Maris et al., 2007 [1]; Brodeur, 2003 [2]). Probability of cure varies according to patient's age, extent of disease and tumor biology (Maris et al., 2007 [1]; Brodeur, 2003 [2]; Cohn et al., 2009...
Main Authors: | Soledad Gómez, Giancarlo Castellano, Gemma Mayol, Ana Queiros, José I. Martín-Subero, Cinzia Lavarino |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-09-01
|
Series: | Genomics Data |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213596015001609 |
Similar Items
-
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.
by: Gemma Mayol, et al.
Published: (2012-01-01) -
Biological Insight and Recent Advancement in the Treatment of Neuroblastoma
by: Zoriamin Rivera, et al.
Published: (2023-05-01) -
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
by: Galván Patricia, et al.
Published: (2010-10-01) -
Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.
by: Laia Masvidal, et al.
Published: (2013-01-01) -
AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia
by: Eliana Gonçalves-Alves, et al.
Published: (2022-04-01)